Front & Back Matter.
- Published in:
- Neurodegenerative Diseases, 2014, v. 14, n. 2, p. X, doi. 10.1159/000367608
- By:
- Publication type:
- Article
Works matching IS 16602854 AND DT 2014 AND VI 14 AND IP 2
Results: 6
1
2
Pyroglutamate-Modified Amyloid-β Protein Demonstrates Similar Properties in an Alzheimer's Disease Familial Mutant Knock-In Mouse and Alzheimer's Disease Brain.
- Published in:
- Neurodegenerative Diseases, 2014, v. 14, n. 2, p. 53, doi. 10.1159/000353634
- By:
- Publication type:
- Article
3
White Matter Changes in Patients with Parkinson's Disease Carrying Small CGG Expansion FMR1 Alleles: A Pilot Study.
- Published in:
- Neurodegenerative Diseases, 2014, v. 14, n. 2, p. 67, doi. 10.1159/000356190
- By:
- Publication type:
- Article
4
Protective Effects of Bexarotene against Amyloid-β<sub>25-35</sub>-Induced Dysfunction in Hippocampal Neurons through the Insulin Signaling Pathway.
- Published in:
- Neurodegenerative Diseases, 2014, v. 14, n. 2, p. 77, doi. 10.1159/000358397
- By:
- Publication type:
- Article
5
Pyroglutamate-Amyloid-β and Glutaminyl Cyclase Are Colocalized with Amyloid-β in Secretory Vesicles and Undergo Activity-Dependent, Regulated Secretion.
- Published in:
- Neurodegenerative Diseases, 2014, v. 14, n. 2, p. 85, doi. 10.1159/000358430
- By:
- Publication type:
- Article
6
Exploring Alzheimer Molecular Pathology in Down's Syndrome Cerebrospinal Fluid.
- Published in:
- Neurodegenerative Diseases, 2014, v. 14, n. 2, p. 98, doi. 10.1159/000358800
- By:
- Publication type:
- Article